Navigation Links
Miltenyi Biotec GmbH Acquires Medic Tools AG
Date:6/10/2008

BERGISCH GLADBACH, Germany, June 10 /PRNewswire/ -- Miltenyi Biotec has acquired Medic Tools AG from Zug, Switzerland. With this acquisition, Miltenyi Biotec strengthens the portfolio in the area of sample preparation. "The innovative and high-quality devices and techniques fit perfectly into the product range of instruments, reagents, and services offered by Miltenyi Biotec", Miltenyi Biotec CEO Dr. Boris Stoffel and Franz G. Bucher, Vice President and CEO of Medic Tools AG, stated in a conjoint announcement.

As a first result of the previous cooperation, the gentleMACS(TM) Dissociator was introduced into the market several months ago. The instrument facilitates the generation of single-cell suspensions from tissues and thus, helps generate the ideal starting material for the separation and isolation of specific cell types using MACS(R) Technology. This procedure to separate cells magnetically was developed by Miltenyi Biotec and is a research laboratory standard worldwide.

The additional expertise of Medic Tools enables Miltenyi Biotec to further engage in development projects in the area of sample preparation. "We offer our biomedical research customers a complete solution", adds Dr. Stoffel, "from sample preparation to cell separation, cell analysis, cytological and molecular analysis."

The involved parties agreed that financial details of the transaction should not be disclosed.

About Miltenyi Biotec

The company is one of the largest and most successful biotechnology companies in Germany. More than 1,100 employees develop, produce and sell products for biomedical research and clinical applications. The renowned MACS Technology for magnetic separation of cells has become a standard technology in research laboratories worldwide.

Contact:

Prof. Dr. Uwe Heinlein, Corporate Communications, Miltenyi Biotec GmbH

Friedrich-Ebert-Str. 68, 51429 Bergisch Gladbach, Germany

Phone +49-2204-8306-6590, E-mail uweh@miltenyibiotec.de

http://www.miltenyibiotec.com


'/>"/>
SOURCE Miltenyi Biotec GmbH
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
2. Brazils biotech firms: From imitators to innovators in health-related products
3. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
4. Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference
5. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
6. InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences
7. Hologic to Present at the Needham Seventh Annual Biotechnology and Medical Technology Conference
8. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
10. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
11. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, ... executives and entrepreneurs, held The Future of San Diego Life Science event at the ... life science community attended the event with speakers Dr. Rich Heyman, former CEO of ...
(Date:5/23/2016)... Texas (PRWEB) , ... May 23, 2016 , ... The need for blood donations in ... this week by the South Texas Blood & Tissue Center, blood donations are on the ... 30 years, and they are down 21 percent in South Texas in the last four ...
(Date:5/23/2016)... WARSAW, Ind. , May 23, 2016 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the second quarter of 2016. ... on or about July 29, 2016 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
(Date:5/23/2016)... LONDON , May 23, 2016 - ... by 40% - Frontage Implement a Single Platform to ... Compliance and Traceability Within the Bioanalytical lab Frontage Laboratories, ... the United States and China , ... its laboratory facilities. In addition to serving as the global electronic ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
Breaking Biology News(10 mins):